EU MDR Device Classification: Classes I, IIa, IIb, III Explained

Published 2026-11-15 · By Ala'a from The Biomedical Index · اقرأ بالعربية

Under the EU MDR, every medical device falls into class I, IIa, IIb or III, and the class is set by applying the 22 classification rules in Annex VIII to the device's intended purpose. Class I devices can be further subdivided into Is (sterile), Im (measuring function) and Ir (reusable surgical instruments). The higher the class, the greater the notified body's involvement in conformity assessment. The manufacturer must record the class, and the justification for the rule or rules applied, in the technical documentation.

Classification is the first regulatory decision a manufacturer makes, and it shapes almost everything that follows. For hospital buyers, importers and distributors, knowing how the class was reached is a quick way to judge whether a supplier's CE marking and certificates make sense. This guide draws on the Medical Device Coordination Group's guidance MDCG 2021-24 Rev.1 (April 2026), which explains the rules in Regulation (EU) 2017/745. You can find the regulation itself in our EU MDR listing. The guidance notes that it is not legally binding and that only the Court of Justice of the EU can give binding interpretations. This article is general information, not legal advice.

1. Why classification matters

The MDCG describes classification as "a risk-based system taking into account the vulnerability of the human body and the potential risks associated with the devices." All devices, whatever their class, must meet the general safety and performance requirements in Annex I. They must also be subject to vigilance reporting, be CE marked (with exceptions for custom-made and investigational devices), and receive a UDI and be registered in the electronic system (see EUDAMED).

Many other obligations depend on class, as the following examples from the guidance show:

• Clinical investigation: For implantable devices and class III devices, a premarket clinical investigation is compulsory, with some exceptions.
• Expert panel review: For class III implantable devices and class IIb active devices intended to administer or remove a medicinal product, the notified body must follow the clinical evaluation consultation procedure involving expert panels.
• Post-market reporting: Class I devices (including Is, Im and Ir) need a post-market surveillance report, available to authorities on request. Class IIa, IIb and III devices need a periodic safety update report. This is updated at least annually for IIb and III devices, and at least every two years for IIa devices.
• Traceability: For class III implantable devices, economic operators and health institutions must keep a record of the UDIs they supply or are supplied with.
• Instructions for use: As an exception to the general rule, class I and IIa devices may be supplied without instructions for use if they can be used safely without them.

2. The four classes and the class I subclasses

Article 51 of the MDR divides devices into classes I, IIa, IIb and III, "taking into account the intended purpose of the devices and their inherent risks." Under Article 52(7), class I devices may be further subdivided as follows:

• Is: devices placed on the market in sterile condition.
• Im: devices with a measuring function. The guidance sets three criteria that must all be met: the device quantitatively measures a parameter or quantity; the result is displayed in legal or other acceptable units, or compared with a reference point in such units; and the intended purpose implies an accuracy whose failure could significantly harm the patient. For example, a plastic syringe co-packed with a medicine to measure the dose falls into this category, but an ungraduated medicine spoon does not.
• Ir: reusable surgical instruments. These are instruments for cutting, drilling, sawing, clamping, retracting and similar tasks, are not connected to an active device, and are intended to be reused after cleaning, disinfection and sterilisation.

3. The classification criteria

The rules combine several criteria: duration of contact, degree of invasiveness, local versus systemic effect, potential toxicity, the part of the body affected, and whether the device depends on a source of energy. The guidance notes that these rules largely correspond to the classification principles of the International Medical Device Regulators Forum (IMDRF).

Duration of use

• Transient: normally intended for continuous use for less than 60 minutes.
• Short term: between 60 minutes and 30 days.
• Long term: more than 30 days.

"Continuous use" ignores temporary interruptions, such as removing a device for cleaning. It also includes immediate replacement with an identical device, such as replacing a ureteric catheter. The guidance offers three illustrations:

• A scalpel used throughout a long operation is still transient, because each cut lasts seconds.
• Contact lenses cleaned overnight count only for their period of uninterrupted wear.
• For a topical cream, duration means how long it remains on the body, not how long it takes to apply.

Invasiveness and anatomy

The guidance defines invasiveness in the following terms:

• Invasive device: a device that penetrates the body, either through a body orifice or through its surface.
• Surgically invasive device: a device that enters through an artificially created opening, even a pinprick. Surgical gloves and needles used with syringes are therefore surgically invasive.
• Stomas: a permanent stoma, such as a colostomy, counts as a body orifice, so devices introduced into it are not surgically invasive.
• Implantable device: a device intended to be totally introduced into the body, or to replace an epithelial surface or the surface of the eye, and to remain in place after the procedure. Partially introduced devices that remain for at least 30 days are also deemed implantable.

The rules also single out two critical anatomical locations: the "central circulatory system" (specified major vessels) and the "central nervous system" (brain, meninges and spinal cord).

Active devices

An active device depends on an energy source other than the human body or gravity. The guidance gives several examples:

• A manual syringe is not active, but a spring-loaded injector preloaded by winding is.
• Elastomeric pumps are active, because body energy is stored in the stretched elastomer.
• Electrodes for ECG or EEG are normally not active.
• Software is an active device.

4. The rule groups

Non-invasive devices (Rules 1-4)

• Rule 1 is the fall-back rule: non-invasive devices are class I unless another rule applies. Examples include hospital beds, wheelchairs, stethoscopes and ultrasound gels.
• Rule 2 covers devices that channel or store substances for eventual administration. These are class IIa if they may connect to an active device of class IIa or higher, or if they handle blood or body liquids (for example, infusion pump tubing). Blood bags are class IIb. Gravity infusion sets are class I.
• Rule 3 covers devices that modify the composition of blood or other liquids. Haemodialysers are class IIb. Filtration, centrifugation, or exchange of gas or heat is class IIa. IVF media without human albumin are class III.
• Rule 4 covers devices in contact with injured skin or mucous membrane:
  • Barrier, compression or absorption dressings are class I.
  • Dressings that manage the wound micro-environment are class IIa.
  • Dressings for wounds that breach the dermis and heal only by secondary intent are class IIb.

Invasive devices (Rules 5-8)

• Rule 5 covers devices invasive through body orifices. Transient use is class I (examination gloves), short term is class IIa (tracheal tubes) and long term is class IIb (urethral stents). Lower classes apply in the oral cavity, ear canal and nasal cavity.
• Rule 6 covers transient surgically invasive devices, which are class IIa by default (needles, lancets). Reusable surgical instruments are class I. Devices for direct use on the heart, central circulatory system or central nervous system are class III (for example, cardiovascular catheters and spinal needles).
• Rule 7 covers short-term surgically invasive devices, which are class IIa by default (clamps, infusion cannulae). Absorbable sutures and temporary pacemaker leads are class III.
• Rule 8 covers implants and long-term surgically invasive devices, which are class IIb by default (dental implants, intra-ocular lenses). Devices placed in the teeth are class IIa. The following are class III:
  • prosthetic heart valves;
  • active implantable devices and their accessories;
  • breast implants and surgical meshes;
  • joint replacements and spinal disc replacements, except components such as screws and plates.

Active devices (Rules 9-13)

• Rule 9 covers active therapeutic devices that administer or exchange energy. These are class IIa (TENS devices, external hearing aids), or class IIb if potentially hazardous (lung ventilators, surgical lasers, infant incubators). Devices that control active implantables, such as pacemaker programmers, are class III.
• Rule 10 covers active diagnosis and monitoring devices:
  • Examination lamps are class I.
  • Electrocardiographs and electronic thermometers are class IIa.
  • ICU patient monitors and diagnostic X-ray and CT equipment are class IIb.
• Rule 11 covers software. Software that provides information for diagnostic or therapeutic decisions is class IIa. It becomes class IIb if those decisions could cause serious deterioration of health or a surgical intervention, and class III if they could cause death or irreversible deterioration. For example, image-analysis software for acute stroke treatment decisions is class III. Monitoring software is class IIa, or class IIb for vital parameters where variations could mean immediate danger. All other software is class I. Software that drives or influences a device takes the same class as that device. See our software category.
• Rule 12 covers active devices that administer or remove substances. Feeding pumps are class IIa. Infusion pumps, ventilators and anaesthesia machines are class IIb.
• Rule 13 covers all other active devices, which are class I (electric wheelchairs, electric hospital beds).

Special rules (Rules 14-22)

• Rule 14: devices with an ancillary medicinal substance are class III (drug-eluting stents, heparin-coated catheters).
• Rule 15: contraception and STD prevention devices are class IIb (condoms), or class III if implantable or long-term invasive.
• Rule 16: contact lens solutions are class IIb. Sterilisers are class IIa. Washer-disinfectors for invasive devices at the end point of processing are class IIb.
• Rule 17: X-ray image recording devices are class IIa.
• Rule 18: devices made with non-viable human or animal tissue or derivatives are class III, unless animal-derived and in contact with intact skin only.
• Rule 19: devices with nanomaterials range from class IIa to class III, depending on the potential for internal exposure.
• Rule 20: inhalation drug delivery devices are class IIa or class IIb.
• Rule 21: substance-based devices range from class IIa to class III. Systemic absorption to achieve the intended purpose places them in class III.
• Rule 22: closed-loop therapeutic systems and automated external defibrillators are class III.

5. Implementing rules: how the rules are applied

• Intended purpose decides. The manufacturer's intended purpose determines the class, not accidental or off-label use, and not the class given to similar products.
• The strictest rule wins. All rules must be considered, and if several rules or sub-rules apply, the one giving the highest class applies.
• Systems can be split or classed as a whole. In the guidance's wound drainage example, the cannula is class IIa and the tubing and collector are class I. The manufacturer may apply class IIa to the whole system or assess the parts separately.
• Disputes go to the competent authority. Disputes between manufacturer and notified body about applying Annex VIII may be referred to the competent authority of the Member State where the manufacturer (or its authorised representative) is registered.

6. What the class means for notified body involvement

Demonstrating conformity is first the manufacturer's responsibility. As the guidance puts it, "the higher the class of the device, the greater the involvement of a notified body." Annexes I to III apply to every device. The conformity assessment procedures in Annexes IX to XI depend on class, and some classes offer a choice of procedure.

The European Commission publishes further guidance. Quality systems are typically built on ISO 13485, and risk files on ISO 14971. Our testing and certification category lists organisations such as BSI Group, TÜV SÜD and DEKRA. Always check any body's MDR designation and scope in the European Commission's NANDO database.

7. Practical checklist for buyers and distributors

1. Ask the manufacturer for the device class and the rule or rules used. The technical documentation must contain both.
2. Check that the class fits the intended purpose stated in the instructions for use and the labelling.
3. For any device above plain class I, request the notified body certificate. Confirm that it covers this device and class, and verify the body in NANDO.
4. Look for "upgrade" triggers, such as connection to active devices, contact with the central circulatory system or CNS, medicinal substances, animal tissue or nanomaterials.
5. For software, ask how the decision impact under Rule 11 was assessed.
6. For class III implantables, plan how you will record UDIs.
7. Check the device's registration in EUDAMED.

8. A note for MENA buyers

If you import into the Middle East or North Africa and a supplier presents EU CE marking as evidence, the same questions apply: which class, which rule, and does the certificate actually cover this device? Local registration is still a separate step. Combine the checks above with our guide to verifying a medical device supplier in the FDA, EUDAMED, SFDA and JFDA registers, and browse manufacturers and regulators and standards in the directory.

Sources

• MDCG 2021-24 Rev.1: Guidance on classification of medical devices (April 2026)
• Regulation (EU) 2017/745: Medical Device Regulation

Facts are taken from the official sources linked in the text as of the publication date. Rules and lists change, so always confirm with the regulator before a purchase or registration decision.